lobbying_activities: 1620545
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1620545 | d60147b9-1b09-45c9-9ae3-4accc61d20a2 | Q4 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2014 | fourth_quarter | PHA | H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. Issues regarding prescription drug coverage for the Department of Defense. Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2015-01-14T14:33:09.270000-05:00 |